FASN and colorectal carcinoma: We recently described a robust CRC-specific lipid signature based on quantitative lipidomics in a multi-cohort and cross-centre study, identifying triacylglycerol species and FASN expression as differential markers of cancerous tissue and bad prognosis, respectively23.